Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1327883

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1327883

DNA Sequencing

PUBLISHED:
PAGES: 392 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 14850

Add to Cart

Description

Table of Contents

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global DNA Sequencing Market to Reach $16 Billion by 2030

In the changed post COVID-19 business landscape, the global market for DNA Sequencing estimated at US$6.5 Billion in the year 2022, is projected to reach a revised size of US$16 Billion by 2030, growing at a CAGR of 11.9% over the analysis period 2022-2030. Consumables, one of the segments analyzed in the report, is projected to record a 11.5% CAGR and reach US$6.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 10.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.7 Billion, While China is Forecast to Grow at 16.2% CAGR

The DNA Sequencing market in the U.S. is estimated at US$2.7 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 16.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.9% and 9.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR.

Select Competitors (Total 76 Featured) -

  • Eppendorf AG
  • Adaptive Biotechnologies Corporation
  • Cofactor Genomics, Inc.
  • Annoroad Gene Technology
  • ADS Biotec, Inc.
  • BGI Genomics Co Ltd.
  • DayTwo
  • Dynasty Gene
  • Clevergene
  • Ares Genetics GmbH
  • DDL Diagnostic Laboratory
  • DelphiTest GmbH
  • DNA link
  • ARL Bio Pharma, Inc.
  • Celgene Corporation
Show more
Product Code: MCP11607

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • DNA Sequencing - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • An Introduction
    • A Brief History on Evolution of DNA Sequencing Technology
    • Different Types of Sequencing Approaches
    • Shotgun Sequencing
    • High-Throughput Approach
    • Long-Read Sequencing Approaches
    • Single Molecule Real Time (SMRT) Sequencing
    • Nanopore DNA Sequencing
    • Short-Read Sequencing Approaches
    • Massively Parallel Signature Sequencing (MPSS)
    • Massively Parallel Signature Sequencing (MPSS)
    • Polony Sequencing
    • 454 Pyrosequencing
    • Illumina (Solexa) Sequencing
    • Combinatorial Probe Anchor Synthesis (cPAS)
    • SOLiD sequencing
    • Ion Torrent Semiconductor Sequencing
    • DNA Nanoball Sequencing
    • Heliscope Single Molecule Sequencing
    • Microfluidic Systems
    • A Prelude to DNA Sequencing
    • Major Applications
    • DNA Sequencing Application
    • Impact of Covid-19 and a Looming Global Recession
    • 2020 Marked as a Year of Disruption & Transformation
    • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021
    • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    • Impact of COVID-19 on DNA Sequencing Market
    • Global Market Prospects and Outlook
    • DNA Sequencing Market Set for a Rapid Growth
    • Regional Market Perspective
    • North America Leads the Global Market
    • Competition
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Next Generation Sequencing Drives the Market Growth
    • Increasing R&D Activities in NGS
    • Illumina, the Dominant Force in the Global NGS Market
    • The Market for DNA Sequencing in Europe amid the Pandemic
    • Growing Adoption of Sequencing Services in Clinical Workflows Propels Market Growth
    • Increasing Use in Drug Discovery Drives Market Growth
    • Increasing Emphasis on Personalized Medicine Drives Market Growth
    • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024
    • Rising Incidence of Cancer to Drive Market Growth
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018
    • Number of New Cancer Cases and Deaths (in Million) by Region for 2018
    • DNA Sequencing and Cancer Care
    • Technological Advancements in NGFS Aids Market Expansion
    • The First Mobile Genome Sequence Analyzer in the World
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Reproductive Health by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Clinical Investigation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Clinical Investigation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Clinical Investigation by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Forensics & Agrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Forensics & Agrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Forensics & Agrigenomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for HLA Typing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for HLA Typing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 27: World 16-Year Perspective for HLA Typing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Consumer Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Consumer Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 30: World 16-Year Perspective for Consumer Genomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 33: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 36: World 16-Year Perspective for Academic Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 39: World 16-Year Perspective for Clinical Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 41: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 42: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 43: World Recent Past, Current & Future Analysis for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 44: World Historic Review for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 45: World 16-Year Perspective for Pharma & Biotech by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 46: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 47: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 48: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 49: World DNA Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 50: USA Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: USA 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: USA 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: USA 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 59: Canada Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: Canada 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: Canada 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2023 & 2030
  • JAPAN
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: Japan 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: Japan 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2023 & 2030
  • CHINA
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: China Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: China 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: China Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: China 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: China Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: China 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2023 & 2030
  • EUROPE
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 86: Europe Recent Past, Current & Future Analysis for DNA Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for DNA Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: Europe 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2023 & 2030
  • FRANCE
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: France Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 100: France 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: France Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 103: France 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: France Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 106: France 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2023 & 2030
  • GERMANY
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 107: Germany Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 112: Germany 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 115: Germany 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 116: Italy Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 118: Italy 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 121: Italy 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 122: Italy Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 124: Italy 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 125: UK Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 127: UK 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 130: UK 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 131: UK Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 133: UK 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 154: Rest of World 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 155: Rest of World Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Rest of World Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 157: Rest of World 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 158: Rest of World Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Rest of World Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 160: Rest of World 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2023 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!